Literature DB >> 22167445

Role of gallium-67 scintigraphy in the evaluation of occult sepsis in the medical ICU.

Wei-Chun Chen1, Kuen-Daw Tsai, Chia-Hung Chen, Ming-Shian Lin, Chuan-Mu Chen, Chuen-Ming Shih, Wei Chen.   

Abstract

Patients in intensive care units (ICUs) frequently have multiple infections or persistent fever despite management. The aim of this study was to evaluate the diagnostic contribution of gallium-67 scintigraphy in ICU patients with suspected occult sepsis. One hundred and seventeen patients (>18 years) who had undergone gallium-67 scintigraphy in the ICU of our medical center over a 3-year period were retrospectively reviewed and analyzed. Patients were categorized into Group 1 (n = 84), those with a known infectious source, but who still had persistent fever or sepsis despite antibiotic treatment or abscess drainage; or Group 2 (n = 33), those without an evident infectious source after clinical, physical, and imaging studies. Among the 117 patients, 19 (16.2%) had a new diagnosis. In Group 1, 12 patients (14%) had a new infection, including pneumonia (4 patients), bed sore infection (2 patients), pulmonary tuberculosis (2 patients), leg cellulitis (1 patient), psoas muscle abscess (1 patient), osteomyelitis (1 patient), and infective endocarditis (1 patient). In Group 2, seven patients (21.2%) had a new infectious source, including septic arthritis (3 patients), osteomyelitis (2 patients), neck abscess (1 patient), and cholecystitis (1 patient). Significant differences were not observed between patients with positive and negative findings on gallium-67 scintigraphy in characteristics, underlying diseases, laboratory data, and outcomes. Gallium-67 scintigraphy helped to detect new or additional infectious sites, particularly bone, joint, and soft tissues. However, differences in hospital stay and mortality were not observed between patients with positive and negative findings.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22167445     DOI: 10.1007/s11739-011-0739-8

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  22 in total

1.  Gallium-67 citrate imaging before and after treatment of acute Q fever.

Authors:  Jong-Kang Lee
Journal:  Clin Nucl Med       Date:  2003-12       Impact factor: 7.794

2.  Chest CT and gallium-67 SPECT scintigraphy scan co-registration in a post-heart transplantation patient with unresolved fever.

Authors:  Ahuva Grubstein; Hanna Bernstine; Adam P Steinmetz
Journal:  Isr Med Assoc J       Date:  2007-11       Impact factor: 0.892

3.  The role of gallium-67 imaging in the detection of foci in recent cases of fever of unknown origin.

Authors:  K Suga; K Nakagi; T Kuramitsu; K Itou; N Tanaka; H Uchisato; T Nakanishi; H Utsumi; N Yamada
Journal:  Ann Nucl Med       Date:  1991-03       Impact factor: 2.668

4.  Tc-99m HMPAO labelled WBCs in the detection of occult sepsis in the intensive care unit.

Authors:  C H Kao; Y L Wang; S Q Liao; S J Wang
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

5.  The clinical use of 99m-Tc-labeled WBC scintigraphy in critically ill surgical and trauma patients with occult sepsis.

Authors:  G Minoja; M Chiaranda; A Fachinetti; M Raso; L Dominioni; D Torre; D De Palma
Journal:  Intensive Care Med       Date:  1996-09       Impact factor: 17.440

Review 6.  Techniques for evaluating fever in the ICU. A stepwise approach for detecting infectious and noninfectious causes.

Authors:  R J Green; D E Clarke; R S Fishman; T A Raffin
Journal:  J Crit Illn       Date:  1995-01

Review 7.  Fever in the ICU.

Authors:  P E Marik
Journal:  Chest       Date:  2000-03       Impact factor: 9.410

Review 8.  Role of radionuclide imaging in the diagnosis of postoperative infection.

Authors:  C J Palestro; C Love; G G Tronco; M B Tomas
Journal:  Radiographics       Date:  2000 Nov-Dec       Impact factor: 5.333

9.  Clinical value of gallium-67 scintigraphy in the investigation of fever or inflammation of unknown origin in the ultrasound and computed tomography era.

Authors:  D C Knockaert; L A Mortelmans; M C Deroo; H J Bobbaers
Journal:  Acta Clin Belg       Date:  1989       Impact factor: 1.264

10.  The role of gallium-67 scintigraphy in diagnosing sources of fever in ventilated patients.

Authors:  G U Meduri; J M Belenchia; J D Massie; M Eltorky; E A Tolley
Journal:  Intensive Care Med       Date:  1996-05       Impact factor: 17.440

View more
  6 in total

1.  How to Avoid Nontherapeutic Laparotomy in Patients With Multiple Organ Failure of Unknown Origin. The Role of CT Scan Revisited.

Authors:  Stephanie Li Sun Fui; Renato Micelli Lupinacci; Christophe Trésallet; Matthieu Faron; Gaelle Godiris-Petit; Harika Salepcioglu; Severine Noullet; Fabrice Menegaux
Journal:  Int Surg       Date:  2015-03

2.  Targeting post-infarct inflammation by PET imaging: comparison of (68)Ga-citrate and (68)Ga-DOTATATE with (18)F-FDG in a mouse model.

Authors:  James T Thackeray; Jens P Bankstahl; Yong Wang; Mortimer Korf-Klingebiel; Almut Walte; Alexander Wittneben; Kai C Wollert; Frank M Bengel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-08-12       Impact factor: 9.236

3.  Potential usefulness of FDG PET/CT in patients with sepsis of unknown origin.

Authors:  Jing-Ren Tseng; Ke-Yuan Chen; Ming-Hsun Lee; Ching-Tai Huang; Ying-Hao Wen; Tzu-Chen Yen
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

4.  Biomedical implementation of liquid metal ink as drawable ECG electrode and skin circuit.

Authors:  Yang Yu; Jie Zhang; Jing Liu
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

5.  Injectable 3-D fabrication of medical electronics at the target biological tissues.

Authors:  Chao Jin; Jie Zhang; Xiaokang Li; Xueyao Yang; Jingjing Li; Jing Liu
Journal:  Sci Rep       Date:  2013-12-06       Impact factor: 4.379

Review 6.  Recommendations for the treatment of osteomyelitis.

Authors:  Ana Lucia L Lima; Priscila R Oliveira; Vladimir C Carvalho; Sergio Cimerman; Eduardo Savio
Journal:  Braz J Infect Dis       Date:  2014-04-01       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.